India, March 13 -- The Government of India has issued a release:
S.
Segment
Financial year (FY) 2020-21
FY 2021-22
FY 2022-23
FY 2023-24
FY 2024-25
1
Consumables and disposables
1,290
1,378
1,605
1,752
1,863
2
Surgical instruments
54
71
72
79
86
3
Electromedical equipment
985
1,163
1,335
1,472
1,483
4
Implants
99
135
188
266
350
5
In vitro diagnostic reagents
104
176
191
216
232
Total
2,532
2,923
3,391
3,785
4,014
Financial year
FDI inflows (in crore Rs.)
2018-19
1,108
2019-20
2,196
2020-21
511
2021-22
1,545
2022-23
3,123
2023-24
3,978
2024-25
5,253
2025-26 (up to December, 2025)
2,944
Total
20,658
No.
As per the information received from the Department of Health and Family Welfare, currently 4108 medical device manufacturers are licensed in the country. Out of 4108 medical device manufacturers, 2099 manufacturers are licensed for manufacture of Class A devices, 2560 manufacturers are licensed for manufacture of Class B devices, 1123 manufacturers are licensed for manufacture of Class C devices and 343 manufacturers are licensed for manufacture of Class D devices. Some manufacturers operate across multiple device classes. Production data is not maintained by Central Drugs Standard Control Organization (CDSCO) centrally.
Details of medical devices exported to various countries during the last five years, as per data maintained by the Directorate General of Commercial Intelligence and Statistics, is as follows:
(In million US$)
The financial-year-wise inflow of foreign direct investment (FDI) into the medical device sector for the period since FY2018-19, as per data from the Department for Promotion of Industry and Internal Trade, is as under:
Data regarding domestic investment in the medical device sector is not maintained centrally by any Ministry of the Government of India.
The Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices aims to promote domestic manufacturing of medical devices by attracting large investments for creation of domestic manufacturing capacity and incentivising domestic production. It has a total budgetary outlay of Rs.3,420 crore and a five-year performance-linked incentive period from FY2022-23 to FY2026-27. Under the scheme, selected companies are eligible for financial incentive for incremental sales of domestically manufactured medical devices in the 4 target segments, for a period of five years. A total of 28 applicants have been approved and total incentive amount of Rs.157.15 crore has been disbursed to seven applicants, till December 2025. So far, 24 greenfield projects have been commissioned, and production has started for 57 products, which include high-end medical devices on which the country has been import-dependent, such as linear accelerators, MRI, Ultrasound, CT scans, Mammograms, C-Arm and X-ray machines. Till December 2025, cumulative eligible sales of Rs. 13,624.52 crore including exports sales worth Rs.6,425.48 crores have been made under the scheme.
The Scheme for Promotion of Medical Devices Parks aims to create common infrastructure and testing facilities for increased competitiveness and cost reduction of medical device units through optimisation of resources and economies of scale, thereby leading to better availability and affordability of medical devices in the domestic market. Under the scheme, three parks have been approved and are at an advanced stage of development in Greater Noida (Uttar Pradesh), Ujjain (Madhya Pradesh) and Kanchipuram (Tamil Nadu). The total project cost of these parks is over Rs.871.11 crore, with Central assistance to the tune of Rs.100 crore each, for creation of common infrastructure facilities. Till date, a total amount of Rs.210.00 crore has been disbursed to said three parks as grant-in-aid by the Government of India.
No data regarding self-reliance ratio of the country in critical medical devices such as diagnostic kits, ventilators, stents and implants is maintained by the Government. However, in line with the vision of Atmanirbhar Bharat, Government from time to time has assessed dependence on imports in the medical device sector and has taken steps to improve R&D, quality certification infrastructure and MSME participation in the medical devices sector, including collaborations with academic and research institutions.
In 2020, assessing that the domestic medical devices market was heavily dependent on imports, which contributed to more than 85% of the market, Government launched the PLI Scheme for Promoting Domestic Manufacturing of Medical Devices and the Scheme for Promotion of Medical Devices Parks.
Subsequently, Government announced the National Medical Devices Policy, 2023 as a holistic policy framework to accelerate growth of the sector with a patient-centric approach to meet the evolving healthcare needs of patients. Pursuant to the policy, the following actions, among others, have been undertaken:
No plan is currently under consideration of the Department of Pharmaceuticals to introduce new medical device clusters or technology platforms.
This information was given by Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel, in a written reply in the Lok Sabha today.
Disclaimer: Curated by HT Syndication.
